Prescription Drug Pricing
Editat de Jonathan R. Dickson, Amy M. Woebleren Limba Engleză Hardback – 20 feb 2012
Preț: 750.00 lei
Preț vechi: 1027.11 lei
-27% Nou
Puncte Express: 1125
Preț estimativ în valută:
143.53€ • 148.94$ • 119.97£
143.53€ • 148.94$ • 119.97£
Carte disponibilă
Livrare economică 22 februarie-08 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781613246399
ISBN-10: 1613246390
Pagini: 147
Ilustrații: illustrations
Dimensiuni: 157 x 232 x 14 mm
Greutate: 0.38 kg
Editura: Nova Science Publishers Inc
ISBN-10: 1613246390
Pagini: 147
Ilustrații: illustrations
Dimensiuni: 157 x 232 x 14 mm
Greutate: 0.38 kg
Editura: Nova Science Publishers Inc
Cuprins
Preface; Prescription Drugs: Trends in Usual & Customary Prices for Commonly Used Drugs; Lack of Therapeutically Equivalent Drugs & Limited Competition May Contribute to Extraordinary Price Increases; Overview of Approaches to Control Prescription Drug Spending in Federal Programs; Opening Statement of U.S. Senator Amy Klobuchar, Hearing on "At What Cost? Egregious Price Increases in the Pharmaceutical Drug Industry"; Statement of Senator Charles E Schumer, Chairman, Joint Economic Committee, Hearing on "At What Cost? Egregious Price Increases in the Pharmaceutical Drug Industry"; Statement of Madeline M Carpinelli, Stephen W Schondelmeyer, PRIME Institute, College of Pharmacy, University of Minnesota, Before the Joint Economic Committee, Hearing on "Extraordinary Price Increases in the Pharmaceutical Market"; Testimony of Alan L Goldbloom, MD, President & CEO, Children's Hospitals & Clinics of Minnesota, before the Joint Economic Committee, Hearing on "At What Cost? Egregious Price Increases in the Pharmaceutical Drug Industry"; Testimony of Danielle Foltz, before the Joint Economic Committee, Hearing on "At What Cost? Egregious Price Increases in the Pharmaceutical Drug Industry"; Entry Threats & Pricing in the Generic Drug Industry; Index.